Biohaven Ltd.
BHVN
$14.85
-$2.35-13.66%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.55% | 51.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.45% | 23.76% | |||
| Operating Income | 4.45% | -23.76% | |||
| Income Before Tax | 10.49% | -18.35% | |||
| Income Tax Expenses | -57.14% | 1,168.75% | |||
| Earnings from Continuing Operations | 10.61% | -18.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.61% | -18.64% | |||
| EBIT | 4.45% | -23.76% | |||
| EBITDA | 4.37% | -24.21% | |||
| EPS Basic | 10.99% | -17.61% | |||
| Normalized Basic EPS | 10.69% | -22.58% | |||
| EPS Diluted | 10.99% | -17.61% | |||
| Normalized Diluted EPS | 10.69% | -22.58% | |||
| Average Basic Shares Outstanding | 0.42% | 0.88% | |||
| Average Diluted Shares Outstanding | 0.42% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||